- Division of Translational and Clinical Sciences – DTCS
- Review Branch:
- Cancer Therapeutics – CTH
- Study Section:
- Mechanisms of Cancer Therapeutics C – MCTC
Dr. Gloria Su received her Ph.D. in immunology from the University of Chicago. Her post-doctoral training at the Johns Hopkins University School of Medicine focused on identifying tumor suppressor genes and oncogenes important to pancreatic tumorigenesis. She joined the faculty of the Johns Hopkins University and then moved to Columbia University College of Physicians and Surgeons, where she and her team developed novel genetic-engineered mouse models for pancreatic and head and neck cancers, interrogated cellular dysregulations and underlying molecular mechanisms of tumor development, progression, and metastasis, and identified potential targets for chemoprevention and novel therapeutic development. Dr. Su published over 80 original and review articles. She was a chartered member of an NIH study section and served as an ad hoc reviewer on numerous NIH, DOD, and other domestic and international grant agencies. She also served as an editor-in-chief and editorial board member for multiple peer-reviewed journals. Dr. Su left Columbia University at the rank of Professor to join CSR.